This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Can ZYN and IQOS Sustain Philip Morris' Smoke-Free Surge?
by Zacks Equity Research
IQOS and ZYN power PM's smoke-free growth in Q2, now accounting for more than 40% of revenues and gross profit.
Will Strong Pricing Power Offset Altria's Volume Declines in 2025?
by Zacks Equity Research
Altria leans on strong pricing and Marlboro's brand power to offset a drop in cigarette volumes in the second quarter.
Should SPDR Portfolio S&P 500 High Dividend ETF (SPYD) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SPYD
Altria's Q2 Earnings on the Deck: How to Play the Stock
by Swati Prasad
MO's Q2 results are likely to reflect NJOY ACE's market exit and soft cigarette volumes, though pricing strength may help.
MO vs. PM: Which Tobacco Stock Has More Puff Left in 2025?
by Swati Prasad
MO's pricing strength and PM's global smoke-free push show momentum. But which tobacco stock leads now?
Here's Why Philip Morris Raises Its 2025 EPS Guidance Again
by Zacks Equity Research
PM hikes its 2025 EPS guidance as smoke-free products like IQOS and ZYN boost the second-quarter performance.
Philip Morris (PM) Loses 10.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
The heavy selling pressure might have exhausted for Philip Morris (PM) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Is on! the Bright Spot in Altria's Oral Tobacco Portfolio?
by Zacks Equity Research
With rising brand loyalty and expanding reach, on! is reshaping MO's future in the oral nicotine space.
Philip Morris Q2 Earnings Beat Estimates, FY25 EPS View Raised
by Zacks Equity Research
PM lifts full-year outlook as strong second-quarter results show gains in IQOS, ZYN and stable combustibles across regions.
Philip Morris (PM) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Philip Morris (PM) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Philip Morris (PM) Q2 Earnings Top Estimates
by Zacks Equity Research
Philip Morris (PM) delivered earnings and revenue surprises of +3.24% and -1.12%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights Philip Morris International, McDonald's, Texas Instruments and Blue Ridge Bankshares
by Zacks Equity Research
PM, MCD, TXN, and BRBS stand out in Zacks analyst picks, backed by pricing power, innovation, and improved fundamentals.
The Zacks Analyst Blog Highlights Alphabet, Tesla, Coca-Cola, IBM and Philip Morris
by Zacks Equity Research
Alphabet, Tesla, KO, IBM, and PM headline a packed earnings week as global PMI data and policy shifts add fresh market tension.
Top Analyst Reports for Philip Morris, McDonald's & Texas Instruments
by Mark Vickery
Walmart's investments in supply chain, store remodels, and automation are fueling growth across its U.S. and international segments.
Q2 Earnings Season Ramps Up: Global Week Ahead
by John Blank
U.S. corporate earnings season kicks into high gear with market heavyweights Alphabet (GOOGL) and Tesla (TSLA) leading the charge.
Should Philip Morris Stock Be in Your Portfolio Ahead of Q2 Earnings?
by Swati Prasad
PM's second quarter results are likely to benefit from strong pricing and sustained smoke-free momentum despite currency pressures.
Gear Up for Philip Morris (PM) Q2 Earnings: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Beyond analysts' top-and-bottom-line estimates for Philip Morris (PM), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
Philip Morris (PM) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Philip Morris (PM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Behind Altria's Profit Resilience: The Power of Pricing Strategy
by Ansuiya Mohta
MO leans on pricing power to lift profits, offsetting cigarette volume drops and regulatory headwinds.
Will Philip Morris (PM) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Philip Morris (PM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Is Philip Morris' Pricing Power Behind Its Profit Strength?
by Swati Prasad
PM's strong pricing and premium product mix fuel profit growth and margin gains in the nicotine category.
Altria Group Gains 21% in 6 Months: How to Play the Stock?
by Swati Prasad
MO is gaining ground with strong Marlboro pricing, smoke-free growth, and solid value, appealing to income-focused investors.
Philip Morris Gains 21% in 3 Months: How to Play the Stock?
by Swati Prasad
PM is gaining ground with smoke-free products and cost cuts, but regulatory and currency risks call for caution.
MO Strengthens on! Brand: Can it Sustain Momentum in Nicotine Pouches?
by Swati Prasad
Altria gains ground in smoke-free with on! pouches, lifting market share and boosting awareness through bold marketing moves.
PM Grows Smoke-Free Profit Share: Will Margins Keep Expanding?
by Swati Prasad
Philip Morris' smoke-free shift gained momentum in the first quarter of 2025 as high-margin products drove profit growth and strengthened its portfolio mix.